Deutivacaftor
ATC — · 5 markets · 12 records
AU 5 records · 3 strengths
- 125 mgtabletALYFTREKALYFTREK 10/50/125 vanzacaftor (as calcium) 10 mg / tezacaftor 50 mg / deutivacaftor 125 mg film-coated tablet blister pack
- 50 mgtabletALYFTREKALYFTREK 4/20/50 vanzacaftor (as calcium) 4 mg / tezacaftor 20 mg / deutivacaftor 50 mg film-coated tablet blister pack
Records without a stated strength · 1 ALYFTREK
US 2 records · 2 strengths
GB 2 records · 2 strengths
CA 2 records · 2 strengths
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 ALYFTREK
| Strength / form / release | US | GB | CA | AU | EU |
|---|---|---|---|---|---|
| 125 mg tablet | ALYFTREK | ALYFTREK | ALYFTREK | ALYFTREK ALYFTREK 10/50/125 vanzacaftor (as calcium) 10 mg / tezacaftor 50 mg / deutivacaftor 125 mg film-coated tablet blister pack | |
| 50 mg tablet | ALYFTREK | ALYFTREK | ALYFTREK | ALYFTREK ALYFTREK 4/20/50 vanzacaftor (as calcium) 4 mg / tezacaftor 20 mg / deutivacaftor 50 mg film-coated tablet blister pack | |
unknown | ALYFTREK | ALYFTREK |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.